Page last updated: 2024-09-05

bms204352 and atovaquone

bms204352 has been researched along with atovaquone in 2 studies

Compound Research Comparison

Studies
(bms204352)
Trials
(bms204352)
Recent Studies (post-2010)
(bms204352)
Studies
(atovaquone)
Trials
(atovaquone)
Recent Studies (post-2010) (atovaquone)
49112997100420

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)atovaquone (IC50)
Dihydroorotate dehydrogenase Schistosoma mansoni0.431
Cytochrome bHomo sapiens (human)2.835
Dihydroorotate dehydrogenase (quinone), mitochondrialHomo sapiens (human)2.65
Dihydroorotate dehydrogenase (quinone), mitochondrialRattus norvegicus (Norway rat)0.7
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.23

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, TK; Ensom, MH; Kiang, TK1
Lombardo, F; Obach, RS; Waters, NJ1

Reviews

1 review(s) available for bms204352 and atovaquone

ArticleYear
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005

Other Studies

1 other study(ies) available for bms204352 and atovaquone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008